BML Investment Partners, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share (PMVP)

Filing Manager
BML Investment Partners, L.P.
Reporting Manager
BML Investment Partners, L.P.
Security
PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share
Symbol
PMVP
Shares outstanding
53,454,545 shares
Disclosed Ownership
5,292,000 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
09 Feb 2026, 14:19:24 UTC
Date of event
31 Dec 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"BML Investment Partners, L.P. disclosed 9.9% ownership in PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share (PMVP) on 31 Dec 2025."

Quick Takeaways

  • BML Investment Partners, L.P. filed SCHEDULE 13G/A for PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share (PMVP).
  • Disclosed ownership: 9.9%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 09 Feb 2026, 14:19.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BML Investment Partners, L.P. 9.9% 5,292,000 0 5,292,000 Braden M Leonard BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member

Sponsored